AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22976263 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux dialysis membranes
Number of subjects: 80
Study 22976263 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flux dialysis membranes
Number of subjects: 80
Study 22976263 — intervention group
Group type: COMPARATOR
Intervention: Control group (40 volunteers)
Number of subjects: 80
Study 19528280 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-824 (1,500 mg single dose)
Number of subjects: 58
Study 19528280 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-824 (600 mg multiple doses)
Number of subjects: 58
Study 19528280 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-824 (up to 7 days of daily dosing)
Number of subjects: 58
Study 19528280 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-824 (daily dosing)
Number of subjects: 58
Study 17582496 — intervention group
Group type: EXPERIMENTAL
Intervention: TOF-MRA
Number of subjects: 33
Study 17582496 — intervention group
Group type: EXPERIMENTAL
Intervention: CE-MRA
Number of subjects: 33
Study 15068394 — intervention group
Group type: EXPERIMENTAL
Intervention: OGTT (oral glucose tolerance test; 75 g of glucose)
Number of subjects: 39
Study 15068394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 12575212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 84
Study 12575212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg
Number of subjects: 84
Study 12575212 — intervention group
Group type: COMPARATOR
Intervention: Control (no Nifedipine)
Number of subjects: 84
Study 9261032 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal blood pressure responses
Number of subjects: 71
Study 9261032 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal heart rate responses
Number of subjects: 71
Study 9261032 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined abnormal blood pressure and heart rate responses
Number of subjects: 71
Study 8066320 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile single-use catheters
Number of subjects: 30
Study 8066320 — intervention group
Group type: COMPARATOR
Intervention: Clean reused catheters
Number of subjects: 30
Study 8066320 — intervention group
Group type: COMPARATOR
Intervention: Sterile catheters only (from a similar group)
Number of subjects: 30
Study 3557017 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfated G‐17 infusion
Number of subjects: 0
Study 3557017 — intervention group
Group type: COMPARATOR
Intervention: Unsulfated G‐17 infusion
Number of subjects: 0
Study 30506924 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine transdermal ointment 2 mg/cat, applied once daily for 14 ± 3 days
Number of subjects: 177
Study 30506924 — intervention group
Group type: COMPARATOR
Intervention: Placebo, applied once daily for 14 ± 3 days
Number of subjects: 177
Study 27939951 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised exposure testing with feedback on test results
Number of subjects: 42
Study 27939951 — intervention group
Group type: COMPARATOR
Intervention: Sham exposures
Number of subjects: 42
Study 25363659 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniarc suburethral sling
Number of subjects: 50
Study 25363659 — intervention group
Group type: COMPARATOR
Intervention: Monarc suburethral sling
Number of subjects: 50
Study 23027226 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-guided anesthesia
Number of subjects: 921
Study 23027226 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 921
Study 21777873 — intervention group
Group type: EXPERIMENTAL
Intervention: PAS-25 (paired-associative stimulation with PNS preceding TMS by 25 milliseconds)
Number of subjects: 44
Study 21777873 — intervention group
Group type: COMPARATOR
Intervention: PAS-10 (paired-associative stimulation with PNS preceding TMS by 10 milliseconds)
Number of subjects: 44
Study 19472848 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive surgery plus prednisolone
Number of subjects: 88
Study 19472848 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone alone
Number of subjects: 88
Study 17329128 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine administration
Number of subjects: 35
Study 17329128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 17329128 — intervention group
Group type: EXPERIMENTAL
Intervention: Believers in the paranormal
Number of subjects: 35
Study 17329128 — intervention group
Group type: COMPARATOR
Intervention: Skeptics
Number of subjects: 35
Study 14666372 — intervention group
Group type: EXPERIMENTAL
Intervention: Radner Reading Charts (three standardized charts)
Number of subjects: 36
Study 14666372 — intervention group
Group type: EXPERIMENTAL
Intervention: Variance component analyses
Number of subjects: 36
Study 14666372 — intervention group
Group type: EXPERIMENTAL
Intervention: Radner Reading Charts
Number of subjects: 36
Study 11520726 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin
Number of subjects: 12
Study 11520726 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (cyclooxygenase inhibitor)
Number of subjects: 12
Study 11520726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9779520 — intervention group
Group type: EXPERIMENTAL
Intervention: REM-deprivation (RD)
Number of subjects: 26
Study 9779520 — intervention group
Group type: COMPARATOR
Intervention: Yoked-control (YC)
Number of subjects: 26
Study 7899118 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 2 mg/kg IV
Number of subjects: 88
Study 7899118 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 88
Study 7899118 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 88
Study 7899118 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) and Placebo (P)
Number of subjects: 88
Study 3108981 — intervention group
Group type: EXPERIMENTAL
Intervention: Distilled water
Number of subjects: 12
Study 3108981 — intervention group
Group type: COMPARATOR
Intervention: DSCG in distilled water
Number of subjects: 12
Study 3108981 — intervention group
Group type: COMPARATOR
Intervention: DSCG in normal saline
Number of subjects: 12
Study 3108981 — intervention group
Group type: COMPARATOR
Intervention: DSCG in buffered saline
Number of subjects: 12
Study 3108981 — intervention group
Group type: EXPERIMENTAL
Intervention: Coughing during inhalation of nebulised distilled water
Number of subjects: 12
Study 2123287 — intervention group
Group type: EXPERIMENTAL
Intervention: BPF clone infection
Number of subjects: 10
Study 60065 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran
Number of subjects: 0
Study 60065 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch
Number of subjects: 0
Study 60065 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatins
Number of subjects: 0
Study 60065 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma substitutes (general)
Number of subjects: 0
Study 31122895 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance care planning and palliative care interventions
Number of subjects: 0
Study 31122895 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised trials of interventions to improve communication about goals of care
Number of subjects: 0
Study 28138946 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 0
Study 26063454 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept plus MTX
Number of subjects: 419
Study 26063454 — intervention group
Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 419
Study 23472459 — intervention group
Group type: EXPERIMENTAL
Intervention: Argan oil
Number of subjects: 151
Study 23472459 — intervention group
Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 151
Study 21468376 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cefuroxime 1500 mg given as preoperative antimicrobial prophylaxis 30 minutes prior to surgery
Number of subjects: 188
Study 21468376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 19431956 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl cyanoacrylate
Number of subjects: 24
Study 19431956 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 24
Study 16705719 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg alendronate for 2 months and 10 mg for 2 months thereafter
Number of subjects: 51
Study 16705719 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg alendronate for 2 months and 10 mg for 4 months thereafter
Number of subjects: 51
Study 16705719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 14740310 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT
Number of subjects: 80
Study 14740310 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-LCT with pre-treatment of lidocaine
Number of subjects: 80
Study 14740310 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT with pre-treatment of lidocaine
Number of subjects: 80
Study 14740310 — intervention group
Group type: COMPARATOR
Intervention: Propofol-LCT
Number of subjects: 80
Study 11501728 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (ice massage or wax packs, thermal baths, and faradic hand baths)
Number of subjects: 50
Study 11501728 — intervention group
Group type: COMPARATOR
Intervention: Control group (no physical or exercise therapy)
Number of subjects: 50
Study 9243041 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopping antibiotic therapy on day 3 (group A)
Number of subjects: 68
Study 9243041 — intervention group
Group type: COMPARATOR
Intervention: Continuing antibiotic therapy (group B)
Number of subjects: 68
Study 8281594 — intervention group
Group type: EXPERIMENTAL
Intervention: Armoured laryngeal mask airway (LMA)
Number of subjects: 109
Study 8281594 — intervention group
Group type: COMPARATOR
Intervention: Tracheal intubation (ETT)
Number of subjects: 109
Study 3570863 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin supplement
Number of subjects: 60
Study 3570863 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid supplement
Number of subjects: 60
Study 3570863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29587673 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding: Essential Support Skills DVD
Number of subjects: 210
Study 29587673 — intervention group
Group type: COMPARATOR
Intervention: Vaginal delivery DVD
Number of subjects: 210
Study 28545578 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) involving eight workshops lasting 1.5 hours each, conducted weekly for 8 weeks.
Number of subjects: 96
Study 26136584 — intervention group
Group type: EXPERIMENTAL
Intervention: Water and education provision (WEP) group
Number of subjects: 240
Study 26136584 — intervention group
Group type: COMPARATOR
Intervention: Education provision (EP) only group
Number of subjects: 240
Study 26136584 — intervention group
Group type: EXPERIMENTAL
Intervention: WEP group with high water intake (>1200 mL/d)
Number of subjects: 240
Study 23670566 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression services use in various settings (primary care, mental health, substance abuse, homeless services, social services)
Number of subjects: 981
Study 23670566 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling for depression treatment
Number of subjects: 981
Study 23670566 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based depression care
Number of subjects: 981
Study 21172952 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 44370 TA 400 mg
Number of subjects: 461
Study 21172952 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 40 mg
Number of subjects: 461
Study 21172952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 461
Study 21172952 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 44370 TA 200 mg
Number of subjects: 461
Study 21172952 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 44370 TA 50 mg
Number of subjects: 461
Study 18583261 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone (4 mg/day)
Number of subjects: 118
Study 18583261 — intervention group
Group type: COMPARATOR
Intervention: sulfonylureas
Number of subjects: 118
Study 16247610 — intervention group
Group type: EXPERIMENTAL
Intervention: Clotrimazole 100 mg vaginal pessaries for 6 days, 2 gm secnidazole, and 150 mg fluconazole as single therapy.
Number of subjects: 72
Study 16247610 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole 100 mg vaginal pessaries for 6 days, combination kit containing 150 mg fluconazole, 2 gm secnidazole, and 1 gm azithromycin.
Number of subjects: 72
Study 12235022 — intervention group
Group type: EXPERIMENTAL
Intervention: Monosodium glutamate (MSG) 150 mg/kg body weight
Number of subjects: 7
Study 12235022 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 10217372 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day)
Number of subjects: 24
Study 10217372 — intervention group
Group type: COMPARATOR
Intervention: Placebo (one tablet/day)
Number of subjects: 24
Study 8610776 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocervical prostaglandin E2 gel
Number of subjects: 285
Study 8610776 — intervention group
Group type: COMPARATOR
Intervention: Vaginal prostaglandin E2 gel
Number of subjects: 285
Study 1970961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam
Number of subjects: 20
Study 1970961 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole 40-50 mg/kg for 3 days
Number of subjects: 360
Study 540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole 100 mg coated tablets
Number of subjects: 360
Study 540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole 40-50 mg/kg
Number of subjects: 360
Study 540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole for G. lamblia infections
Number of subjects: 360
Study 540079 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole for E. histolytica infections
Number of subjects: 360
Study 30016633 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute intravesical contrast followed by sterile saline
Number of subjects: 48
Study 30016633 — intervention group
Group type: COMPARATOR
Intervention: Non-dilute intravesical contrast
Number of subjects: 48
Study 26985727 — intervention group
Group type: EXPERIMENTAL
Intervention: Family‐ and church‐based intervention
Number of subjects: 124
Study 26985727 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124
Study 25424918 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16/18 AS04-adjuvanted vaccine
Number of subjects: 437
Study 22670574 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group therapy program
Number of subjects: 39
Study 19969423 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent protocol (HDS with gauze as secondary covering)
Number of subjects: 70
Study 19969423 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelled protocol (HDS with transparent film as secondary covering)
Number of subjects: 70
Study 19969423 — intervention group
Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 70
Study 19969423 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherent protocol
Number of subjects: 70
Study 19969423 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelled protocol
Number of subjects: 70
Study 17590368 — intervention group
Group type: EXPERIMENTAL
Intervention: Mud-bath treatment (12 mud packs and 12 thermal baths over a period of two weeks)
Number of subjects: 24
Study 17590368 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mud-bath treatment)
Number of subjects: 24
Study 15452586 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP rs1136141 in HSPA8
Number of subjects: 288
Study 15452586 — intervention group
Group type: COMPARATOR
Intervention: Control group (1025 controls)
Number of subjects: 288
Study 12102471 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 117
Study 12102471 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 117
Study 10460040 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b and ribavirin
Number of subjects: 400
Study 10460040 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b alone
Number of subjects: 400
Study 7791257 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 262
Study 7791257 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 262
Study 7791257 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 262
Study 2112337 — intervention group
Group type: EXPERIMENTAL
Intervention: ISDN spray, 2.5 mg
Number of subjects: 12
Study 2112337 — intervention group
Group type: COMPARATOR
Intervention: sublingual NTG, 0.8 mg
Number of subjects: 12
Study 91774 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated group (polyvalent pseudomonas vaccine)
Number of subjects: 107
Study 91774 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated group
Number of subjects: 107
Study 31401603 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen therapy (HFOT) alone
Number of subjects: 280
Study 31401603 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen therapy (HFOT) with non-invasive ventilation (NIV)
Number of subjects: 280
Study 27860460 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 25
Study 27860460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 25730661 — intervention group
Group type: EXPERIMENTAL
Intervention: Demonstration-based training
Number of subjects: 52
Study 25730661 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation participation
Number of subjects: 52
Study 25730661 — intervention group
Group type: COMPARATOR
Intervention: Didactic instruction
Number of subjects: 52
Study 25730661 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 52
Study 24378660 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Hz
Number of subjects: 12
Study 24378660 — intervention group
Group type: EXPERIMENTAL
Intervention: I-Freq
Number of subjects: 12
Study 24378660 — intervention group
Group type: COMPARATOR
Intervention: Control (no vibration)
Number of subjects: 12
Study 21955688 — intervention group
Group type: EXPERIMENTAL
Intervention: DBSint®
Number of subjects: 31
Study 21955688 — intervention group
Group type: EXPERIMENTAL
Intervention: SINTlife®
Number of subjects: 31
Study 21955688 — intervention group
Group type: COMPARATOR
Intervention: lyophilised bone chips
Number of subjects: 31
Study 19296949 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing position and early ambulation after cardiac catheterization
Number of subjects: 70
Study 19296949 — intervention group
Group type: COMPARATOR
Intervention: Routine management with 10-24h bed rest in supine position
Number of subjects: 70
Study 17475960 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F‐FLT PET
Number of subjects: 10
Study 15044426 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial management programme
Number of subjects: 0
Study 15044426 — intervention group
Group type: COMPARATOR
Intervention: Non-intensive care areas
Number of subjects: 0
Study 15044426 — intervention group
Group type: COMPARATOR
Intervention: Intensive care areas
Number of subjects: 0
Study 12532614 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate (1 or 2 drops applied directly on the incision)
Number of subjects: 60
Study 12532614 — intervention group
Group type: COMPARATOR
Intervention: Traditional nylon suturing (Control Group)
Number of subjects: 60
Study 9583331 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential treatment
Number of subjects: 261
Study 9583331 — intervention group
Group type: COMPARATOR
Intervention: Day treatment
Number of subjects: 261
Study 2069605 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness program (details not specified)
Number of subjects: 48
Study 2069605 — intervention group
Group type: COMPARATOR
Intervention: Demographic and social characteristics (gender, income, ethnicity)
Number of subjects: 48
Study 6364459 — intervention group
Group type: EXPERIMENTAL
Intervention: doxorubicin + cyclophosphamide + vincristine
Number of subjects: 100
Study 6364459 — intervention group
Group type: COMPARATOR
Intervention: CCNU + vincristine
Number of subjects: 100
Study 30793285 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 1037
Study 30793285 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Standard of Care
Number of subjects: 1037
Study 29669181 — intervention group
Group type: COMPARATOR
Intervention: Arm A (70 Gy of radiation with cisplatin)
Number of subjects: 189
Study 29669181 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B (70 Gy of radiation with cisplatin plus erlotinib at 150 mg daily)
Number of subjects: 189
Study 29669181 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 189
Study 29669181 — intervention group
Group type: EXPERIMENTAL
Intervention: Black race (independent predictor)
Number of subjects: 189
Study 26812050 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 57
Study 24598885 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B-12 supplementation (50 μg daily)
Number of subjects: 366
Study 22856186 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel-bead delivery of Eimeria oocysts
Number of subjects: 0
Study 22856186 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral gavage of Eimeria oocysts
Number of subjects: 0
Study 22856186 — intervention group
Group type: COMPARATOR
Intervention: Spray vaccination with Eimeria oocysts mixture
Number of subjects: 0
Study 22856186 — intervention group
Group type: COMPARATOR
Intervention: Nonimmunized control group
Number of subjects: 0
Study 20738316 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin (5 pmol/kg/min)
Number of subjects: 21
Study 18422391 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose valsartan 160-320 mg/day
Number of subjects: 450
Study 18422391 — intervention group
Group type: COMPARATOR
Intervention: Low-dose valsartan 80 mg/day (VALVACE trial)
Number of subjects: 450
Study 15858804 — intervention group
Group type: COMPARATOR
Intervention: Montelukast
Number of subjects: 0
Study 12519437 — intervention group
Group type: EXPERIMENTAL
Intervention: WBC-reduced RBC with low residual WBC concentration
Number of subjects: 105